lmmunomodulation - a disease-modifying avenue for treatment of Huntington's disease?

被引：3
|
作者：
Bjorkqvist, Maria [1 ]
机构：
[1] Lund Univ, Wallenberg Neurosci Ctr, Dept Expt Med Sci, Brain Dis Biomarker Unit, BMC A10, S-22184 Lund, Sweden
来源：
JOURNAL OF NEUROCHEMISTRY | 2016年 / 137卷 / 05期
关键词：
PATHWAY;
D O I：
10.1111/jnc.13539
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
[No abstract available]
引用
收藏
页码：670 / 672
页数：3
相关论文
共 50 条
  • [1] Delivering a disease-modifying treatment for Huntington's disease
    Godinho, Bruno M. D. C.
    Malhotra, Meenakshi
    O'Driscoll, Caitriona M.
    Cryan, John F.
    DRUG DISCOVERY TODAY, 2015, 20 (01) : 50 - 64
  • [2] Trial of disease-modifying treatment for Huntington's begins
    不详
    PROGRESS IN NEUROLOGY AND PSYCHIATRY, 2015, 19 (06) : 34 - 34
  • [3] Disease-modifying treatment approaches in Huntington disease Past and future
    Frank, Wiebke
    Lindenberg, Katrin S.
    Muhlback, Alzbeta
    Lewerenz, Jan
    Landwehrmeyer, G. Bernhard
    NERVENARZT, 2022, 93 (02): : 179 - 190
  • [4] Nanoparticles as disease-modifying mediators for brain therapy: focus on Huntington's disease
    Godinho, B. M. D. C.
    Ogier, J. R.
    Darcy, R.
    O'Driscoll, C. M.
    Cryan, J. F.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 : S52 - S53
  • [5] Nanoparticles as disease-modifying mediators for brain therapy: focus on Huntington's disease
    Godinho, B. M. D. C.
    Ogier, J. R.
    Darcy, R.
    O'Driscoll, C. M.
    Cryan, J. F.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 : S545 - S545
  • [6] Huntington's disease: progress toward effective disease-modifying treatments and a cure
    Johnson, Carl D.
    Davidson, Beverly L.
    HUMAN MOLECULAR GENETICS, 2010, 19 : R98 - R102
  • [7] The search for disease-modifying treatment for Alzheimer's disease
    Aisen, PS
    Davis, KL
    NEUROLOGY, 1997, 48 (05) : S35 - S41
  • [8] Disease-modifying treatment approaches for Alzheimer's disease
    Froelich, Lutz
    Hausner, Lucrezia
    NERVENARZT, 2021, 92 (12): : 1239 - 1248
  • [9] Therapeutic Update on Huntington's Disease: Symptomatic Treatments and Emerging Disease-Modifying Therapies
    Dash, Deepa
    Mestre, Tiago A.
    NEUROTHERAPEUTICS, 2020, 17 (04) : 1645 - 1659
  • [10] Disease-modifying effects of ganglioside GM1 in Huntington's disease models
    Alpaugh, Melanie
    Galleguillos, Danny
    Forero, Juan
    Morales, Luis Carlos
    Lackey, Sebastian W.
    Kar, Preeti
    Di Pardo, Alba
    Holt, Andrew
    Kerr, Bradley J.
    Todd, Kathryn G.
    Baker, Glen B.
    Fouad, Karim
    Sipione, Simonetta
    EMBO MOLECULAR MEDICINE, 2017, 9 (11) : 1537 - 1557
12345